- Home
- BLDR vs MDGL Comparison
BLDR vs MDGL Comparison
Compare BLDR & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | MDGL |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.5B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLDR | MDGL |
|---|---|---|
| Price | $124.51 | $515.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 14 |
| Target Price | $140.16 | ★ $580.77 |
| AVG Volume (30 Days) | ★ 1.7M | 319.8K |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $15,653,056,000.00 | $740,640,000.00 |
| Revenue This Year | N/A | $435.63 |
| Revenue Next Year | N/A | $52.56 |
| P/E Ratio | $23.71 | ★ N/A |
| Revenue Growth | N/A | ★ 864.21 |
| 52 Week Low | $94.35 | $265.00 |
| 52 Week High | $175.12 | $615.00 |
Technical Indicators
Market Signals| Indicator | BLDR | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 70.02 | 34.03 |
| Support Level | $103.50 | $532.45 |
| Resistance Level | $112.65 | $589.98 |
| Average True Range (ATR) | 4.19 | 22.89 |
| MACD | 1.87 | -8.88 |
| Stochastic Oscillator | 99.18 | 1.07 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.